Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimodipine vs. Verapamil ER for RCVS
NCT03150524Phase 4Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Jul 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nimodipine, verapamil in Reversible cerebral vasoconstriction syndrome (RCVS), sponsored by Johns Hopkins University. Planned start Jul 2017; status: withdrawn.
02
Drugs
nimodipineverapamil
03
Conditions
Reversible cerebral vasoconstriction syndrome (RCVS)
Beyond the preview
Go deeper on NCT03150524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03150524.